
Management of HER2-Altered Non-Small Cell Lung Cancer
Oncology Today with Dr Neil Love
00:00
TDM1 and Lung Cancer
Lung cancer is really chemo plus IO which lung cancer really defined that. And a lot of thought process needs to be put in terms of clinical trial design to maximize these immune effects of Tresty's baby. So there were actually quite a few papers on this. The international trial of TDM1 wasn't that impressive, but it showed a 0% response in HER2 2+, and a very low response rate in HER2 3+. But maybe a signal in these amplified cases with TDM1.
Transcript
Play full episode